Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Randomized Controlled Study on Neuromodulation Through Active tDCS Versus Sham tDCS to Support Upper Limb Motor and Functional Recovery in Sub-acute, Incomplete, Tetraplegic Spinal Cord Injured Patients

NCT05390853 is registered in ClinicalTrials.gov with Montecatone Rehabilitation Institute S.p.A. as lead sponsor.

NCT NCT05390853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05390853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Randomized Controlled Study on Neuromodulation Through Active tDCS Versus Sham tDCS to Support Upper Limb Motor and Functional Recovery in Sub-acute, Incomplete, Tetraplegic Spinal Cord Injured Patients
Lead sponsor
Montecatone Rehabilitation Institute S.p.A.
Phase
Not applicable
Overall status
Terminated
Start date
May 24, 2023
Completion date
June 27, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury cervical